| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,181 | 4,921 | 3,592 | 6,031 | | Cost of Revenue | (80) | 80 |
-
|
-
| | | Gross Profit | 3,261 | 4,841 | 3,592 | 6,031 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 999 | 591 | 545 | 4,673 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (568) | 4,249 | 3,048 | 1,358 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,674 | 957 | (2,527) | (4,408) | | Earnings Before Interest And Taxes | 7,687 | 5,513 | 464 | (4,568) | | Interest Expense | 957 | 942 | 931 | (2,734) | | Income Before Tax | 6,730 | 4,571 | (468) | (1,834) | | Income Tax Expense | (1,372) | 526 | 57 | (885) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,351 | 3,739 | (468) | 570 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,037 | 3,739 | (468) | 570 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,037 | $3,739 | ($468) | $570 |
|
0.41% Nasdaq 
Income Statement
